Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #664533 on NorthWest Biotherapeutics Inc (NWBO)
FeMike
01/16/24 4:12 PM
#664534 RE: GoodGuyBill #664533
exwannabe
01/16/24 4:13 PM
#664535 RE: GoodGuyBill #664533
By mid-March... give or take two weeks... NWBO will have DCVAX-L approval. You heard it here, folks.
TheFollower
01/16/24 4:24 PM
#664541 RE: GoodGuyBill #664533
dstock07734
01/16/24 4:46 PM
#664548 RE: GoodGuyBill #664533
The facility’s construction began in November 2021 with an estimated investment of $365m. The facility is expected to be operational by June 2024, creating up to 400 full-time jobs upon completion.
The targeted start date for this position will be in the winter and/or spring of 2024. The position will be a direct manufacturing support role primarily on the shop floor within our Quality Line Oversight team. This team rotates through the vaccine filling and packaging departments at the West Point site providing quality and compliance oversight to our 24/7 manufacturing operations.
03/28/24 11:52 AM
#681838 RE: GoodGuyBill #664533
iclight
03/28/24 1:41 PM
#681895 RE: GoodGuyBill #664533